Nvidia says it had no new H20 sales to China in Q2 and assumes the same for Q3, but could realize $2B-$5B in H20 sales in Q3 if geopolitical issues are resolved
*NVIDIA COMMENTS ON US GOVT ‘EXPECTATION’ TO GET 15% OF H20 REV — *NVIDIA: ANY REQUEST FOR % OF REV “MAY SUBJECT US TO LITIGATION” — *NVIDIA: US GOVT HAS NOT PUBBED REGULATION CODIFYING 15% @fintwitter : NVIDIA in Q2 gained $180 million from the release of previously reserved H20 inventory, tied to roughly $650 million in unrestricted H20 sales to customers outside China. @pistachiosnapper : With all the Nvidia hype & Trump wanting 15% of the companies sales to China, there has been zero sales of these H20 chips in the 2nd quarter. Looks like China doesn't want American chips🤔. [image]
Context & Ripple Effects
Earlier coverage showed export restrictions turning H20 access into a licensing issue, including Nvidia's disclosed $5.5B charge tied to the new H20 licensing rules. A later account of Nvidia's effort to restart H20 sales made a resumption look possible, but this update shows that possibility has not yet translated into new China revenue.
The added uncertainty is not only geopolitical: Nvidia says the government's reported 15% revenue expectation has not been codified, while warning that such a requirement could invite litigation. That leaves the commercial terms as unsettled as market access.
First-order effects
- Nvidia recorded no new H20 sales to China in Q2 and is planning Q3 on the same basis, even as it identifies $2B–$5B of potential Q3 sales if the issues are resolved.
- The company can recognize limited revenue from previously reserved inventory sold outside China, but its China-facing H20 outlook remains contingent; an uncodified revenue-share expectation adds legal and compliance risk.
Second-order effects
- Chinese customers and Nvidia's channel partners have little basis to schedule H20 deployments until export access and the associated terms are clearer, extending procurement delays.
- A prolonged supply gap gives alternative AI-compute suppliers more room with Chinese buyers; earlier coverage had already contrasted expected H20 volumes with projected Huawei Ascend 910B sales in the market.
Third-order effects
- If access to export-controlled AI chips remains subject to shifting licenses and potential revenue-sharing conditions, cross-border accelerator sales may become less predictable and more legally complex than ordinary product exports.
- The episode reinforces a second-source-compute dynamic: buyers exposed to policy-constrained supply have stronger incentives to qualify alternatives, though the pace depends on whether H20 sales actually resume.
The trend: AI-chip trade is shifting from a volume-driven export business toward policy-conditioned access, making supply continuity and alternative sourcing strategic for buyers.